Professor Usha Menon

MRC Clinical Trials Unit at UCL @MRCCTU @UCL Research focus early detection, risk prediction ovarian cancer, enhancing the clinical trials ecosystem in India

[Professor Usha Menon @Prof_UMenon]

I’m getting ready for #ESGO2021 later this month. See you there! https://t.co/VZOFo2QIt3

[Lesley Fallowfield @FallowfieldLJ]

Very disappointing after 20 years hard work on largest ovarian cancer screening trial in world, we did not reduce deaths. But this MUST not deter women from seeking treatment when they have symptoms https://t.co/1RmNQ1LZsB

[Professor Usha Menon @Prof_UMenon]

@uclnews @MaxParmarMRCUCL @MRCCTU @UCLPopHealthSci @eveappeal @CR_UK @NIHRresearch @NIHR @TheLancet Indebted to the women, the funding agencies @NIHR, @CRUKresearch @eveappeal @UCLHresearch, @MRC the UKCTOCS team and everyone from the ovarian cancer community for their support. @ProfManchanda @ProfIJJacobs

[UCL News @uclnews]

Annual screening for ovarian cancer did not succeed in reducing deaths from the disease, despite one screening method detecting cancers earlier, according to a trial involving over 200,000 women led by @Prof_UMenon & Prof @MaxParmarMRCUCL @MRCCTU #UKCTOCS https://t.co/2RBmsEquGC

[Professor Usha Menon @Prof_UMenon]

CDSA @THSTIFaridabad @DBTIndia and @MRCCTU working together to make a difference #ClinicalTrial Tool Kit India @Shinjini_Bhtngr . Thank you Dr Swarup @RenuSwarup for the launch

[G Kang @GKangInd]

Prof. Usha Menon describing the Clinical Trials Toolkit developed at CDSA with CDSCO review. Launched a minute later by @RenuSwarup at GlobalBio India. @DBTIndia supporting the clinical research ecosystem in India.